| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dynavax Technologies Corp (DVAX) has 7 insiders with recent SEC Form 4 filings, including 2 buys and 12 sells. DVAX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 379.6K | $5.84M | - | |
| COO | 85.7K | - | - | |
| VP | 69.6K | $1.07M | - | |
| CFO | 60.2K | $925.9K | - | |
| Dir | 35.0K | $378.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 | Ostrach Michael S | Senior Vice President | Sale+OE | 35,444 | $8.94 | $316,764.10 | -14.7% | |
| Dec 6, 2018 | Cano Francis | Director | Sell | 2,000 | $10.47 | $20,942.00 | -100% | |
| Jun 8, 2018 | Ostrach Michael S | Senior Vice President | Sell | 4,000 | $15.53 | $62,100.00 | -5.0% | |
| Mar 15, 2018 | Novack David F73 | Senior Vice President | Sell | 16,109 | $16.30 | $262,604.09 | -100% | |
| Mar 13, 2018 | Novack David F73 | Senior Vice President | Sell | 34,214 | $16.52 | $565,105.15 | -36.6% | |
| Mar 9, 2018 | Novack David F73 | Senior Vice President | Sell | 2,121 | $17.97 | $38,111.16 | -1.4% | |
| Jan 4, 2018 | Johnson David Louis | Vice President | Sell | 3,092 | $18.60 | $57,511.20 | -39.6% | |
| Dec 13, 2017 | Coffman Robert | Senior Vice President | Sale+OE | 7,500 | $18.90 | $141,750.00 | -54.3% | |
| Jan 24, 2017 | Janssen Robert71 | Vice President | Buy | 6,000 | $4.04 | $24,240.00 | +99.2% | |
| Jun 28, 2016 | Janssen Robert71 | Vice President | Buy | 1,452 | $13.68 | $19,863.36 | +31.6% |